Function of CD19 in B-cell Development & Differentiation
Function of CD19 in B-cell Development & Differentiation
批准号:
6730668
负责人:
ROBERT C RICKERT
金额:
$30.4万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2005-03-31
关键词:
B lymphocyteCD antigensCD19 moleculebiological signal transductioncell differentiationdevelopmental immunologyenzyme activityenzyme mechanismgenetically modified animalslaboratory mouseleukocyte activation /transformationlymphocyte proliferationphosphatidylinositol 3 kinasephosphatidylinositolsphosphomonoesterasesprotein protein interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): B cell activation is initiated by tyrosine phosphorylation of proximal cytosolic and membrane bound adaptor proteins to allow branching of signaling pathways, such as the phosphatidylinositol 3-kinase (PI3K) pathway. Phosphoinositide metabolism is thought to be of key importance to aspects of B cell activation, proliferation, differentiation and survival. PI3K activity is induced by the BCR and amplified by p85alpha recruitment to CD19 and perhaps other cytosolic adaptor proteins. Phosphatidylinositol-3,4,5-trisphosphate (PIP3,4,5) is generated by PI3K in activated cells, leading to the recruitment of pleckstrin-homology (PH)-containing proteins and conformation induced activation of other binding partners, Excessive production of PIP3,4,5 leads to autoimmunity or transformation and is tightly regulated by the inositol phosphatases PTEN and SHIP. The overall goal of this renewal is to understand the context of PIP3,4,5 regulation in B cell differentiation and maintenance. Central to this goal is a detailed understanding of phosphoinositide metabolism in B cells with a particular focus on the opposing enzymatic activities of PI3-kinase, PTEN and SHIP in regulating levels of PIP3,4, 5 and its incumbent role in the recruitment and activation of signaling intermediates. CD19 is the primary activator of PI3K in B cells, leading to the production of PIP3,4 and PIP3,4,5, while the inositol phosphatase PTEN acts to attenuate PIP3,4,5 accumulation by conversion to PIP4,5. Fc-gamma-RIIB1 (CD32) can also attenuate PIP3,4,5 levels through the recruitment of SHIP phosphatase, which converts PIP3,4,5 to PIP3,4. These findings suggest an interplay of CD19 and CD32 function focused on the regulated production of PIP3,4,5 and its ability to recruit and activate downstream effectors. Herein we explore the molecular basis and physiologic significance of CD19 and CD32 function in the regulated production of PIP3,4, PIP4,5 and PIP3,4,5 as key secondary messengers to effect cell fate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a non-canonical role for Foxo1 in B cell lymphoma
-
批准号:8920519
-
项目类别:
-
资助金额:$21.21万
-
财政年份:2014
-
负责人:ROBERT C RICKERT
-
依托单位:
Characterization of a non-canonical role for Foxo1 in B cell lymphoma
-
批准号:8692377
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2014
-
负责人:ROBERT C RICKERT
-
依托单位:
Characterization of Twixt: a novel membrane adaptor protein in B cells
-
批准号:8369296
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2012
-
负责人:ROBERT C RICKERT
-
依托单位:
Functional Antagonists of EBI12/GPR183 as chemical probes for inflammation
-
批准号:8441575
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2012
-
负责人:ROBERT C RICKERT
-
依托单位:
Characterization of Twixt: a novel membrane adaptor protein in B cells
-
批准号:8496712
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2012
-
负责人:ROBERT C RICKERT
-
依托单位:
Follicular dendritic cells and B cell tolerance
-
批准号:8431334
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2012
-
负责人:ROBERT C RICKERT
-
依托单位:
Follicular dendritic cells and B cell tolerance
-
批准号:8321386
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2012
-
负责人:ROBERT C RICKERT
-
依托单位:
Functional Antagonists of EBI12/GPR183 as chemical probes for inflammation
-
批准号:8328179
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2012
-
负责人:ROBERT C RICKERT
-
依托单位:
Elucidating IKK1 function in germinal center B cell differentiation
-
批准号:8053310
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2010
-
负责人:ROBERT C RICKERT
-
依托单位:
Elucidating IKK1 function in germinal center B cell differentiation
-
批准号:7918323
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2010
-
负责人:ROBERT C RICKERT
-
依托单位:
Functional distinctions of IgM vs. IgG-containing B cell receptors
-
批准号:8077304
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2010
-
负责人:ROBERT C RICKERT
-
依托单位:
Functional distinctions of IgM vs. IgG-containing B cell receptors
-
批准号:7761181
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2010
-
负责人:ROBERT C RICKERT
-
依托单位:
Inflammation-regulated microRNA in B cell lymphoma
-
批准号:8076384
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2008
-
负责人:ROBERT C RICKERT
-
依托单位:
Modeling B cell Lymphoma in the Mouse
-
批准号:8043584
-
项目类别:
-
资助金额:$58.45万
-
财政年份:2008
-
负责人:ROBERT C RICKERT
-
依托单位:
Modeling B cell Lymphoma
-
批准号:7802866
-
项目类别:
-
资助金额:$47.75万
-
财政年份:2008
-
负责人:ROBERT C RICKERT
-
依托单位:
Modeling B cell Lymphoma in the Mouse
-
批准号:7474785
-
项目类别:
-
资助金额:$47.75万
-
财政年份:2008
-
负责人:ROBERT C RICKERT
-
依托单位:
Modeling B cell Lymphoma in the Mouse
-
批准号:8033616
-
项目类别:
-
资助金额:$10.7万
-
财政年份:2008
-
负责人:ROBERT C RICKERT
-
依托单位:
Modeling B cell Lymphoma in the Mouse
-
批准号:7597154
-
项目类别:
-
资助金额:$47.75万
-
财政年份:2008
-
负责人:ROBERT C RICKERT
-
依托单位:
Inflammation-regulated microRNA in B cell lymphoma
-
批准号:7674039
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2008
-
负责人:ROBERT C RICKERT
-
依托单位:
Regulation of plasma cell differentiation by PI3-kinase
-
批准号:7497605
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2007
-
负责人:ROBERT C RICKERT
-
依托单位:
海外基金